Eleven NIH Institutes Just Said They Will Fund Extreme Weather Health Research. None of Them Posted a NOFO.
September 18, 2026 · 7 min read
Granted Research Team · Editorial policy
On September 1, 2026, NIH published a Highlighted Topic titled Health and Extreme Weather: Advancing Critical Research to Address the Direct and Indirect Health Impacts of Weather-Related Natural Disasters and Emerging Weather-Related Harms. It carries eleven awarding institutes, four additional participating offices, and an expiration date of May 1, 2028.
It also carries no money.
That is not a criticism — it is the mechanism. A Highlighted Topic is not a Notice of Funding Opportunity. There is no opportunity number to cite on an SF-424, no set-aside, no dedicated review panel, and no deadline of its own. It is a published statement of scientific interest that you attach yourself to by applying through an existing parent announcement and asking to be assigned to the right institute.
Understanding exactly what that buys you — and what it does not — is the difference between a strategically placed application and a misrouted one.
The mechanics
Applications go in through NIH's parent announcements. For small businesses, that means:
- SBIR: PA-27-100 (R43/R44)
- STTR: PA-27-102 (R41/R42)
These are the omnibus parent announcements that went live earlier this year, covered in our PA-27-100/102 breakdown. Investigator-initiated academic teams use the corresponding parent R01, R21, or R03 announcements.
Submission runs on the standard NIH receipt dates: January 5, April 5, and September 5. There is no special cycle. Award start typically follows submission by about nine months.
Which produces the first hard constraint: the topic expires May 1, 2028, making April 5, 2028 the last usable submission date. Counting forward from today, that leaves exactly five windows — January 5 2027, April 5 2027, September 5 2027, January 5 2028, and April 5 2028. If your first submission goes in on the January 2027 date and gets an unfundable score, you have four resubmission chances inside the topic's life, and an A1 resubmission consumes one of them. Plan the arc backward from April 2028, not forward from now.
The second mechanic is assignment. Because the topic has no NOFO of its own, the only way to reach the institute that cares about your work is the cover letter. Name the institute you want, name the topic by title, and name the program officer you have spoken to. An application about heat exposure in older adults that lands at NIEHS when it should have landed at NIA, or vice versa, is not a scientific problem — it is a routing failure that costs a full cycle to fix.
The institute list is not a list. It is a gradient.
Here is where most readers will stop reading and should not. Eleven awarding institutes looks like breadth. Read the individual institute statements and the breadth collapses into a hierarchy.
Awarding institutes: NIEHS (lead), NCCIH, NCI, NHLBI, NIA, NIAID, NIAMS, NIDDK, NIMH, NIMHD, NINR.
Participating without awarding funds: OBSSR, ODP, ORWH, and the Tribal Health Research Office.
Within the awarding group, the commitment language varies materially:
- NIEHS — the only institute stating it may dedicate available funds and may give special consideration. NIEHS is the program lead, houses the NIH Program on Health and Extreme Weather, and identifies protecting health from extreme weather and disasters as a named area in its strategic plan. This is the institute with an institutional stake in the topic's success.
- NIMHD, NCCIH, NIDDK, and NINR — indicated that special consideration is possible. Weaker than a funding commitment, stronger than silence.
- The remaining six — NCI, NHLBI, NIA, NIAID, NIAMS, NIMH — made no formal statement beyond appearing on the list.
That gradient is the most actionable information in the entire document, and it is easy to miss because the topic page presents the institutes as a set. A small business building a wearable heat-exposure sensor can plausibly route to NIEHS, NIAMS, or NIA. Only one of those three has said it might set money aside.
The practical rule: route to the institute whose stated commitment is strongest among those whose science genuinely fits. Do not route to the strongest commitment if the fit is a stretch — study sections notice, and a misfit application at a committed institute scores worse than a good fit at a silent one. But where two institutes are both defensible, the commitment language breaks the tie.
What the topic is actually asking for
The research framing is broader than "climate health," and the product-facing language is unusually specific for an NIH topic. Explicitly welcomed:
- Wearable devices and environmental sensors for exposure assessment — flagged by NIAMS in the musculoskeletal context.
- Care continuity technologies for the failure modes disasters create: lack of access to medications, and electricity-dependent treatments that stop working when power does. NIDDK's framing here is essentially a product spec — dialysis, insulin cold chain, and powered durable medical equipment during outages.
- Data infrastructure — methods to advance the aggregation, linking, accessibility, and interpretation of health and weather-related data. This is the least crowded lane and the most reusable across institutes.
- Mental health measurement instruments and digital interventions for post-disaster populations.
- Infectious disease diagnostics and anti-infective susceptibility tools, reflecting the post-flood and post-storm pathogen exposure pathway.
Two observations about that list. First, it skews heavily toward devices, software, and data rather than mechanism-of-disease research — which is why the SBIR/STTR pathway is prominent and why this topic is more accessible to a fifteen-person hardware company than most NIH topics are. Second, the direct/indirect distinction in the title is doing real work: NIH is signaling interest in the downstream health effects of weather events — displacement, treatment interruption, mental health sequelae, supply chain failure — not only in heat stroke and drowning.
The small business numbers, and the clinical trial traps
For companies weighing this, the SBIR/STTR ceilings under current SBA guidelines:
| Phase | Ceiling (total costs) | Duration |
|---|---|---|
| Phase I | $323,090 | 6 months – 2 years |
| Phase II | $2,153,927 | 1 – 3 years |
| Commercialization Readiness Pilot | $4,191,495 | — |
Several institutes publish higher Phase I headroom than the SBA baseline; confirm the current figure with program staff for your target institute before you build the budget, because the number that matters is the institute's, not the guideline's.
Eligibility is the standard SBIR/STTR gate: a U.S.-based for-profit small business, more than 50 percent owned by U.S. citizens or permanent residents, with no more than 500 employees including affiliates. For SBIR, the PI's primary employment must be with the company; for STTR, the PI may be employed by either the company or the nonprofit research partner. No cost share is required at Phase I or Phase II.
The traps are in the clinical trial policies, which are institute-specific and inconsistent — the single most expensive thing to discover late:
- NIAMS accepts no clinical trials under either SBIR or STTR.
- NIDDK and NIMHD do not accept trials under STTR; NIDDK does accept them under SBIR.
- NCCIH does not support efficacy or effectiveness trials at Phase I, but accepts them at Phase II and in Fast-Track applications.
- NIAID directs small business trials to a separate cooperative agreement mechanism entirely.
A digital mental health intervention that requires a pilot efficacy trial has a completely different institute map than a passive sensor that does not. Determine whether your aims constitute an NIH-defined clinical trial before you choose the institute, not after.
The program-wide contact is Ashlinn Quinn at NIEHS, who also serves as the NIEHS scientific contact. For a topic with no NOFO, that conversation is not optional courtesy — it is the only way to learn which institutes have money moving this cycle.
The strategic read
Highlighted Topics have become NIH's instrument for coordinating scientific interest across institutes without the budgetary commitment a NOFO implies. That is a real trade: the agency gets a cross-cutting signal published in weeks instead of a multi-institute NOFO negotiated over a year; applicants get a topic they can point to but no reserved dollars.
The cost of that trade falls almost entirely on applicants who cannot read the difference. An investigator who treats a Highlighted Topic as a funding opportunity will write to it as if there were a set-aside and a targeted review panel, and will then compete in an unmodified parent-announcement pool against applications that made no such assumption. An investigator who treats it correctly writes a strong investigator-initiated application, cites the topic in the cover letter as an assignment argument, and lets the science carry the score.
There is one more thing worth noticing. The word "climate" appears nowhere in the topic title. The framing throughout is extreme weather, weather-related natural disasters, and emerging weather-related harms — the vocabulary that NIEHS has standardized around in its strategic plan and its program name. For teams that have spent the last two years watching climate-labeled federal research lines contract, the operative lesson is not that the science disappeared. It is that it is being funded under a different noun, through eleven institutes, with no NOFO to search for — which means the researchers most likely to find it are the ones who read Highlighted Topics.
Five submission windows remain. The first one that matters is January 5, 2027, and the institute conversation that determines whether your application is competitive should happen in October.